Fabrice André

基本信息

Career Trajectory

Bio

Le Pr Fabrice André est auteur et co-auteur de 350 publications scientifiques parues dans des revues internationales et figure dans la liste des chercheurs les plus cités au monde (Highly cited researchers list de Web of Science Group). Il est classé parmi les 25 personnalités les plus influentes dans le domaine de la médecine de précision par le think tank BIS Research. Il a été distingué par les prix Young Investigator et Career Development Award de l’American Society of Clinical Oncology (ASCO). Il est rédacteur en chef de la prestigieuse revue internationale Annals of Oncology.

Research Interests

Papers共 1090 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Exploring the Role of ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer T Cell Immune Surveillance Disruption

Morgane Lopez, Laurie Spehner,Fabrice André,Julien Viot,Evan Seffar,Amélie Marguier,Elsa Curtit,Guillaume Meynard,Erion Dobi,Sylvain Ladoire,Romain Boidot, Romain Loyon, Valentin Derangere,François-Clément Bidard, Christophe Borg,Laura Mansi, Marie Kroemer

Breast Cancer Researchno. 1 (2025): 1-15

Cited0Views0WOSBibtex

TP53-associated Early Breast Cancer: New Observations from a Large Cohort

Renata L. Sandoval,Michele Bottosso,Tianyu Li,Natalia Polidorio,Brittany L. Bychkovsky,Benjamin Verret,Alessandra Gennari,Sophie Cahill,Maria Isabel Achatz,Olivier Caron, Marion Imbert-Bouteille,Catherine Nogues, Kara N. Mawell,Cristina Fortuno,Amanda B. Spurdle,Nabihah Tayob,Fabrice Andre,Judy E. Garber

JNCI Journal of the National Cancer Institute (2024)

Cited1Views0WOSBibtex

Pionera Breast Cancer (BC): Phase III Study of First-Line (1L) Giredestrant Vs. Fulvestrant, Both Combined with a Cyclin-Dependent Kinase 4/6 Inhibitor (cdk4/6i), in Patients (pts) with Estrogen Receptor-Positive (ER+), HER2-locally Advanced/metastatic BC (la/mbc) with Resistance to Prior Adjuvant (adj) Endocrine Therapy (ET)

Kevin Kalinsky,Rinath Jeselsohn,Meritxell Bellet,Peter A. Fasching,Gonzalo Gomez-Abuin,Kyung Hae Jung, Sandrine Lavalle,Vanesa L. Prime Opez-Valverde,Yen-Shen Lu,Richard B. Schwab,Nick Turner,Vanessa Breton,Alberto Zambelli,Fabrice Andre

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

Cited0Views0Bibtex

Liquid Biopsy Versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases

Radiologyno. 2 (2024): e232674-e232674

Cited0Views0WOSBibtex

New Clinical Trials in CUP and a Novel Paradigm in Cancer Classification

Elie Rassy,Fabrice Andre

NATURE REVIEWS CLINICAL ONCOLOGYno. 12 (2024): 833-834

Cited0Views0WOSNATUREBibtex

Cancer Biomarkers: Emerging Trends and Clinical Implications for Personalized Treatment

Antonio Passaro,Maise Al Bakir,Emily G. Hamilton,Maximilian Diehn,Fabrice Andre,Sinchita Roy-Chowdhuri,Giannis Mountzios,Ignacio I. Wistuba,Charles Swanton,Solange Peters

Cellno. 7 (2024): 1617-1635

Cited1Views0WOSBibtex

Unlocking the Potential of AI-assisted Pathology for Molecular Alteration Screening

Mihaela Aldea,Maria Rosa Ghigna,Magali Lacroix-Triki,Fabrice Andre

European Journal of Cancer (2024)

Cited0Views0Bibtex

Antibody-drug Conjugates in Lung and Breast Cancer: Current Evidence and Future Directions – a Position Statement from the ETOP IBCSG Partners Foundation

S. Peters,S. Loi,F. André,S. Chandarlapaty,E. Felip,S.P. Finn,P.A. Jänne,K.M. Kerr,E. Munzone,A. Passaro,M. Pérol,E.F. Smit,C. Swanton,G. Viale,R.A. Stahel

Annals of Oncology（2024）

Cited0Views0WOSBibtex

A Phase 3 Study of Gedatolisib Plus Fulvestrant with and Without Palbociclib in Patients with HR+/HER2-advanced Breast Cancer Previously Treated with a CDK4/6 Inhibitor Plus a Non-Steroidal Aromatase Inhibitor (VIKTORIA-1)

Sara Hurvitz,Fabrice Andre,Massimo Cristofanilli,Giuseppe Curigliano,Antonio Giordano,Hyo Han,Miguel Martin,Barbara Pistilli,Hope Rugo,Robert Wesolowski,Igor Gorbatchevsky,Sibylle Loibl

CANCER RESEARCHno. 9 (2024)

Cited0Views0Bibtex

A Bio-Behavioral Model of Systemic Inflammation at Breast Cancer Diagnosis and Fatigue of Clinical Importance Two Years Later

A. Di Meglio,J. Havas,M. Pagliuca,M. A. Franzoi,D. Soldato, C. K. Chiodi, E. Gillanders, F. Dubuisson,V. Camara-Clayette,B. Pistilli, J. Ribeiro,F. Joly,P. H. Cottu,O. Tredan,A. Bertaut,P. A. Ganz, J. Bower,A. H. Partridge,A. L. Martin,S. Everhard,S. Boyault, S. Brutin,F. Andre, S. Michiels, C. Pradon,I. Vaz-Luis

ANNALS OF ONCOLOGYno. 11 (2024): 1048-1060

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Professor

Papers共 1090 篇Author StatisticsCo-AuthorSimilar Experts